Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2131771 | 0.86 | TSHR (0.47) | TSHRALDH1A1PPARAPKMCYP1A2 | |
| SCHEMBL10583241 | 0.85 | ALDH1A1 (0.52) | ALDH1A1MAPTL3MBTL1CYP1A2CYP2C19 | |
| SCHEMBL29199291 | 0.80 | ALDH1A1 (0.50) | ALDH1A1MAPTL3MBTL1PKMCYP1A2 | |
| SCHEMBL9571993 | 0.79 | TSHR (0.53) | TSHRL3MBTL1PPARAKDM4E | |
| SCHEMBL5255523 | 0.78 | ALDH1A1 (0.65) | ALDH1A1MAPTL3MBTL1PKMCYP1A2 | |
| SCHEMBL10178554 | 0.78 | TSHR (0.52) | TSHRALDH1A1MAPTL3MBTL1PPARA | |
| SCHEMBL18427871 | 0.77 | ALDH1A1 (0.47) | ALDH1A1MAPTL3MBTL1CYP1A2CYP2C19 | |
| SCHEMBL8209562 | 0.77 | ALDH1A1 (0.51) | ALDH1A1MAPTL3MBTL1CYP1A2CYP2C19 | |
| SCHEMBL17193847 | 0.77 | ALDH1A1 (0.47) | ALDH1A1MAPTL3MBTL1CYP1A2CYP2C19 | |
| SCHEMBL11580414 | 0.77 | ALDH1A1 (0.59) | TSHRALDH1A1MAPTL3MBTL1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210170045-A1 | RELEASABLE ANTIBODY CONJUGATES | FISH & RICHARDSON PC | 2021-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210170045-A1 | RELEASABLE ANTIBODY CONJUGATES | BCR, CD47, RNASE1 | TSHR 1139/4885ALDH1A1 263/4885MAPT 1404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.